2-butyl-2-oxazoline

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-butyl-2-oxazoline
• 英文别名: 2-butyloxazole；2-butyl-1,3-oxazole
• 化学式: C₇H₁₁NO
• 分子量: 125.17
• InChiKey: ABSYEGWQFLNILN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  26
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  N-[(1S,2R,3S,4R)-3-hydroxy-2-bicyclo[2.2.1]hept-5-enyl]pentanamide 以0%的产率得到
  参考文献：
  名称：

  Eissenstat Michael A., Weaver John D. (III), J. Org. Chem., 58 (1993) N 12, S 3387-3390

  摘要：

  DOI：

文献信息

• THERAPEUTIC SUBSTITUTED THIAZOLIDINONES, OXAZOLIDINONES, AND RELATED COMPOUNDS
  申请人：Old W. David

  公开号：US20080058387A1

  公开（公告）日：2008-03-06

  A compound having a structure is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.

  本文披露了一种具有结构的化合物。还披露了与其相关的治疗方法、组成物和药物。
• SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS
  申请人：Allergan, Inc

  公开号：US20140323510A1

  公开（公告）日：2014-10-30

  Disclosed herein is a compound of the formula Therapeutic methods, compositions, and medicaments, related thereto are also disclosed.

  本文披露了一种式子为的化合物。同时还披露了与此相关的治疗方法、组合物和药物。
• METAL CATALYST FOR RING-OPENING POLYMERIZATION OF HETEROCYCLIC COMPOUND
  申请人：SANYO CHEMICAL INDUSTRIES, LTD.

  公开号：EP1340780A1

  公开（公告）日：2003-09-03

  The object of the present invention is to provide a metal catalyst which allows the production of a ring-opened polymer available from a heterocyclic compound, having primary terminal heteroatomic groups (terminal hydroxyl groups, in particular) in a ratio exceeding 75%. The above object can be attained by using a metal catalyst comprising a ligand and a metal atom for ring-opening polymerization of heterocyclic compounds    in which, of all maximum angles (D) meeting the following definition, the smallest maximum angle (Dm) is not larger than 60 degrees; The maximum angle (D) is the largest angle between an imaginary line (X) and an imaginary line (Y) of all the angles which can be assumed in a metal catalyst comprising a ligand and a metal atom,    said imaginary line (X) means a line perpendicular to an imaginary plane (P) including the respective centers of 3 coordinating atoms among those directly coordinating the metal atom (M) and not substitutable by a reaction substrate (S) and passing through the center of the metal atom,    said imaginary line (Y) means a line linking the center of a non-coordinating atom in the ligand and the center of the metal atom,    and said maximum angle (D) exists in a number equal to the number of non-coordinating atoms, that is, the number of imaginary lines (Y).

  本发明的目的是提供一种金属催化剂，该催化剂可以从杂环化合物中生产开环聚合 物，该杂环化合物具有初级末端杂原子基团（特别是末端羟基），其比例超过 75%。 使用由配体和金属原子组成的金属催化剂进行杂环化合物的开环聚合，可达到上述目的 其中，在所有符合以下定义的最大角度 (D) 中，最小的最大角度 (Dm) 不大于 60 度； 最大角度 (D) 是指在由配体和金属原子组成的金属催化剂中，假想线 (X) 和假想线 (Y) 之间的最大角度、 所述假想线 (X) 是指垂直于假想平面 (P) 的一条线，假想平面 (P) 包括直接配位金属原子 (M) 的 3 个配位原子各自的中心，且不能被反应底物 (S) 取代，并通过金属原子的中心、 所述虚线 (Y) 是指连接配体中的非配位原子中心和金属原子中心的一条线、 所述最大角度 (D) 的存在数量等于非配位原子的数量，即虚线 (Y) 的数量。
• Compound for the treatment of paget's disease of bone
  申请人：TEIJIN LIMITED

  公开号：EP1342796A2

  公开（公告）日：2003-09-10

  To obtain a treating agent for Paget's disease of bone, there is provided a method of inhibiting expression of general transcription factor of steroid hormone receptor.

  为了获得一种治疗骨埙病的药物，提供了一种抑制类固醇激素受体一般转录因子表达的方法。
• BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
  申请人：Shanghai de Novo Pharmatech Co., Ltd.

  公开号：EP3453707A1

  公开（公告）日：2019-03-13

  Disclosed are a benzazepine derivative, a preparation method, a pharmaceutical composition and the use thereof. A compound as shown in formula (I) of the present invention, and an isomer, a prodrug, a stable isotope derivative or a pharmaceutically acceptable salt thereof have the following structure. The benzazepine derivative of the present invention has a good regulation effect on the TLR family and the related signalling pathway, and in particular, has a good regulation effect on TLR8, can effectively treat, relieve and/or prevent various diseases mediated by TLR family and the TLR-related signalling pathway, and in particular, can effectively treat, relieve and/or prevent various diseases mediated by TLR8, such as cancers, autoimmune diseases, infections, inflammations, transplantation rejections, graft-versus-host diseases, etc.

  本发明公开了一种苯扎西平衍生物、一种制备方法、一种药物组合物及其用途。本发明的式(I)所示化合物及其异构体、原药、稳定同位素衍生物或药学上可接受的盐具有如下结构。本发明的苯并氮杂卓衍生物对TLR家族及相关信号通路具有良好的调节作用，特别是对TLR8具有良好的调节作用，能有效治疗、缓解和/或预防由TLR家族及TLR相关信号通路介导的各种疾病，特别是能有效治疗、缓解和/或预防由TLR8介导的各种疾病，如癌症、自身免疫性疾病、感染、炎症、移植排斥、移植物抗宿主疾病等。